In head-to-head clinical trial, Chinese firm Akeso’s ivonescimab beat top-selling drug pembrolizumab sold as Keytruda by ...
The union government has reduced GST on three cancer drugs from 12% to 5%, following an earlier exemption from basic customs ...
Take a look at these three top-ranked, best-performing and well-managed mutual funds if you're looking to maximize your retirement portfolio returns. These three top-ranked, best-performing and ...